Czerniel, J.;                     Gostyńska-Stawna, A.;                     Sommerfeld-Klatta, K.;                     Przybylski, T.;                     Krajka-Kuźniak, V.;                     Stawny, M.    
        Development and Validation of In Vitro Assessment Protocol of Novel Intravenous Nanoemulsions for Parenteral Nutrition. Pharmaceutics 2025, 17, 493.
    https://doi.org/10.3390/pharmaceutics17040493
    AMA Style
    
                                Czerniel J,                                 Gostyńska-Stawna A,                                 Sommerfeld-Klatta K,                                 Przybylski T,                                 Krajka-Kuźniak V,                                 Stawny M.        
                Development and Validation of In Vitro Assessment Protocol of Novel Intravenous Nanoemulsions for Parenteral Nutrition. Pharmaceutics. 2025; 17(4):493.
        https://doi.org/10.3390/pharmaceutics17040493
    
    Chicago/Turabian Style
    
                                Czerniel, Joanna,                                 Aleksandra Gostyńska-Stawna,                                 Karina Sommerfeld-Klatta,                                 Tomasz Przybylski,                                 Violetta Krajka-Kuźniak,                                 and Maciej Stawny.        
                2025. "Development and Validation of In Vitro Assessment Protocol of Novel Intravenous Nanoemulsions for Parenteral Nutrition" Pharmaceutics 17, no. 4: 493.
        https://doi.org/10.3390/pharmaceutics17040493
    
    APA Style
    
                                Czerniel, J.,                                 Gostyńska-Stawna, A.,                                 Sommerfeld-Klatta, K.,                                 Przybylski, T.,                                 Krajka-Kuźniak, V.,                                 & Stawny, M.        
        
        (2025). Development and Validation of In Vitro Assessment Protocol of Novel Intravenous Nanoemulsions for Parenteral Nutrition. Pharmaceutics, 17(4), 493.
        https://doi.org/10.3390/pharmaceutics17040493